Global purchasing managers have been seeking to de-risk procurement from China for many years. They have been working on this, but post-COVID and due to recent geopolitical challenges, this trend has accelerated.
Brokerages stay bullish on Laurus Labs as CDMO momentum and margins improve
Laurus Labs’ stock has surged 30% on robust FY26 results, fueled by a booming contract manufacturing business and improved product mix. The company is investing